Actively Recruiting
Fecal Microbiota Transplantation in Postoperative Crohn's Disease
Led by Tampere University Hospital · Updated on 2022-10-27
20
Participants Needed
2
Research Sites
341 weeks
Total Duration
On this page
Sponsors
T
Tampere University Hospital
Lead Sponsor
T
Turku University Hospital
Collaborating Sponsor
AI-Summary
What this Trial Is About
This pilot study aims to detect possible trends or signals suggesting efficacy of FMT on prevention of delay of POR, to determine the safety of FMT in post operative CD, and asses if a full randomised controlled trial is feasible in this setting. With microbiota analysis we aim to assess if changes in gut microbiota are related to disease course of CD after operation.
CONDITIONS
Official Title
Fecal Microbiota Transplantation in Postoperative Crohn's Disease
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Over 18 years
- Able to provide written consent
- Stricturing and/or fistulizing Crohn's disease needing ileocecal or ileal resection
You will not qualify if you...
- Pregnancy
- Active infection, abscess or fistula at the time of the first colonoscopy
- Life expectancy less than 1 year
- Unable to provide written consent
- Use of antibiotics or probiotics at the time of first colonoscopy
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Tampere University Hospital
Tampere, Finland, 33521
Actively Recruiting
2
Tampere University Hospital
Tampere, Finland, 33521
Actively Recruiting
Research Team
E
Elina Jokinen, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
QUADRUPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here